1. Gait, balance, and physical performance as markers of early Alzheimer's disease and related dementia risk.
- Author
-
Tolea MI, Rosenfeld A, Roy SV, Besser LM, O'Shea DM, and Galvin JE
- Abstract
Background: Declining physical functionality is an indicator of cognitive impairment, distinguishing normal cognition (NC) from dementia. Whether this extends to pre-dementia stages is unclear., Objective: Assess physical performance patterns, evaluate relationships with imaging biomarkers, and identify specific measures distinguishing NC, subjective cognitive decline (SCD) and mild cognitive impairment (MCI)., Methods: Group differences (78 NC, 35 SCD, and 41 MCI) in physical function (global function, balance, gait speed, step length, single leg support) were evaluated with logistic regression while distinguishing between MCI due-to-AD and MCI due-to-vascular etiology. Relationships with imaging biomarkers (cortical atrophy score, white matter hyperintensities volumes) were analyzed with ANCOVA., Results: Participants were 68.6 ± 9.3 years old, had 16.2 ± 3.0 years of education, and 23% were ethnoracial minorities. Physical performance distinguished MCI from NC and SCD. Greater performance on the Mini Physical Performance Test (mini PPT) and balance were associated with lower odds of being SCD versus NC (OR
mini PPT = 0.73; 95% CI:0.56-0.97; ORbalance = 0.35, 95%CI:0.16-0.80). AD etiology accounted for most group differences in physical performance versus vascular etiology. Consistent associations between biomarkers, physical performance, and cognition were found., Conclusions: Findings suggest that: 1) changes in mini PPT performance and balance may help detect cognitive impairments, as early as the SCD stage; 2) changes in gait speed, gait cycle parameters, and Timed Up-and-Go may indicate more significant cognitive impairment; 3) neuronal loss is linked to subtle changes in physical functionality as early as SCD. Physical performance may be a valuable tool in early dementia detection in clinical settings and could identify targets for early intervention., Competing Interests: Declaration of conflicting interestsJEG serves on the Board of Directors for the Lewy Body Dementia Association, Lewy Body Resource Center, the South Florida Chapter of the Alzheimer Association and the South Palm Beach County YMCA, as a consultant for Biogen, performs clinical and cognitive evaluations in his clinical practice (15% effort) and bills for these procedures, is funded by NIH grants (R01 AG040211, R01 NS1010483, R01 AG057681, P30 AG059295, U01 NS100610, U54 AG063546, R01 AG056610, R01 AG054425, R01 AG056531, R01 AG040211, R01 NS1010483, R01 AG057681, P30 AG059295, U01 NS100610, U54 AG063546, R01 AG056610, R01 AG054425, and R01 AG056531) and by the Harry T. Mangurian Foundation, and the Leo and Anne Albert Charitable Trust, and receives research support as Director and Principal Investigator of the Lewy Body Dementia Research Center of Excellence from the Lewy Body Dementia Association. JEG is an Editorial Board Member of this journal but was not involved in the peer-review process of this article nor had access to any information regarding its peer- review.The remaining authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.- Published
- 2025
- Full Text
- View/download PDF